These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 15058375)

  • 1. Enamel matrix proteins in the treatment of intra-bony defects. A prospective 24-month clinical trial.
    Francetti L; Del Fabbro M; Basso M; Testori T; Weinstein R
    J Clin Periodontol; 2004 Jan; 31(1):52-9. PubMed ID: 15058375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study.
    Francetti L; Trombelli L; Lombardo G; Guida L; Cafiero C; Roccuzzo M; Carusi G; Del Fabbro M
    Int J Periodontics Restorative Dent; 2005 Oct; 25(5):461-73. PubMed ID: 16250568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary flap closure combined with Emdogain alone or Emdogain and Cerasorb in the treatment of intra-bony defects.
    Bokan I; Bill JS; Schlagenhauf U
    J Clin Periodontol; 2006 Dec; 33(12):885-93. PubMed ID: 17092241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-centre randomized controlled clinical trial on the treatment of intra-bony defects with enamel matrix derivatives/synthetic bone graft or enamel matrix derivatives alone: results after 12 months.
    Meyle J; Hoffmann T; Topoll H; Heinz B; Al-Machot E; Jervøe-Storm PM; Meiss C; Eickholz P; Jepsen S
    J Clin Periodontol; 2011 Jul; 38(7):652-60. PubMed ID: 21564156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enamel matrix proteins in the regenerative therapy of deep intrabony defects.
    Tonetti MS; Lang NP; Cortellini P; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Mayfield L; Rossi R; Silvestri M; Tiedemann C; Topoll H; Vangsted T; Wallkamm B
    J Clin Periodontol; 2002 Apr; 29(4):317-25. PubMed ID: 11966929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
    Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
    J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EDTA gel root conditioning: lack of effect on clinical and radiographic outcomes of intrabony defect treatment with enamel matrix derivative.
    Parashis AO; Tsiklakis K; Tatakis DN
    J Periodontol; 2006 Jan; 77(1):103-10. PubMed ID: 16579710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.
    Pietruska M; Pietruski J; Nagy K; Brecx M; Arweiler NB; Sculean A
    Clin Oral Investig; 2012 Aug; 16(4):1191-7. PubMed ID: 21881869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study.
    Sculean A; Windisch P; Chiantella GC; Donos N; Brecx M; Reich E
    J Clin Periodontol; 2001 May; 28(5):397-403. PubMed ID: 11350501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
    Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
    J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of supra-alveolar-type defects by a simplified papilla preservation technique for access flap surgery with or without enamel matrix proteins.
    Di Tullio M; Femminella B; Pilloni A; Romano L; D'Arcangelo C; De Ninis P; Paolantonio M
    J Periodontol; 2013 Aug; 84(8):1100-10. PubMed ID: 23030240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
    Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
    J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study.
    Wachtel H; Schenk G; Böhm S; Weng D; Zuhr O; Hürzeler MB
    J Clin Periodontol; 2003 Jun; 30(6):496-504. PubMed ID: 12795787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
    Yilmaz S; Cakar G; Yildirim B; Sculean A
    J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of EDTA root conditioning on the healing of intrabony defects treated with an enamel matrix protein derivative.
    Sculean A; Berakdar M; Willershausen B; Arweiler NB; Becker J; Schwarz F
    J Periodontol; 2006 Jul; 77(7):1167-72. PubMed ID: 16805678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enamel matrix derivative in the treatment of human intrabony osseous defects.
    Okuda K; Momose M; Miyazaki A; Murata M; Yokoyama S; Yonezawa Y; Wolff LF; Yoshie H
    J Periodontol; 2000 Dec; 71(12):1821-8. PubMed ID: 11156038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enamel matrix proteins in the treatment of deep intrabony defects.
    Cardaropoli G; Leonhardt AS
    J Periodontol; 2002 May; 73(5):501-4. PubMed ID: 12027251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.
    Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
    Eur J Oral Implantol; 2009; 2(4):247-66. PubMed ID: 20467602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supracrestal soft tissue preservation with enamel matrix proteins in treatment of deep intrabony defects.
    Trombelli L; Bottega S; Zucchelli G
    J Clin Periodontol; 2002 May; 29(5):433-9. PubMed ID: 12060426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
    Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
    J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.